Literature DB >> 2450442

Astrocyte RNA in relation to neuronal RNA depletion in Alzheimer's disease.

J A Doebler1, W R Markesbery, A Anthony, S W Scheff, R E Rhoads.   

Abstract

A new double-staining procedure, in which the techniques of immunocytochemistry of glial fibrillary acidic protein (GFAP) and quantitative microdensitometry of azure B-RNA were combined, was used to study nucleic acid alterations in fibrous astrocytes in Alzheimer's disease (AD). RNA contents of GFAP-positive cells of the hippocampal endplate (Rose's H3-H5 fields) and the dentate gyrus molecular layer were determined in ten autopsy-proven AD patients (ages 51-88) and ten age-matched, non-demented controls. In addition, RNA contents of pyramidal neurons of the endplate were examined. While there were no differences in RNA contents of astrocytes of either region between AD patients and controls, neuronal RNA was markedly depleted. These data suggest that astrocytes maintain protein synthetic capabilities in AD and that RNA loss is limited to the neuronal compartment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2450442     DOI: 10.1007/bf00690535

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  21 in total

1.  Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization.

Authors:  G R Taylor; G I Carter; T J Crow; J A Johnson; A F Fairbairn; E K Perry; R H Perry
Journal:  Exp Mol Pathol       Date:  1986-02       Impact factor: 3.362

Review 2.  Alzheimer's disease: errors in gene expression.

Authors:  D R McLachlan; P N Lewis
Journal:  Can J Neurol Sci       Date:  1985-02       Impact factor: 2.104

3.  Aspects of scanning microdensitometry. I. Stray light (glare).

Authors:  D J Goldstein
Journal:  J Microsc       Date:  1970       Impact factor: 1.758

4.  A method for in situ cytophotometric estimation of absolute amount of ribonucleic acid using azure B1.

Authors:  J R Shea
Journal:  J Histochem Cytochem       Date:  1970-02       Impact factor: 2.479

5.  Nerve cell protein metabolism and degenerative disease.

Authors:  D M Mann
Journal:  Neuropathol Appl Neurobiol       Date:  1982 May-Jun       Impact factor: 8.090

6.  Status spongiosus in Creutzfeldt-Jakob disease.

Authors:  T Miyakawa; S Katsuragi; Y Koga; S Moriyama
Journal:  Clin Neuropathol       Date:  1986 Jul-Aug       Impact factor: 1.368

Review 7.  DNA damage and chronic neuronal degenerations.

Authors:  S H Robison; W G Bradley
Journal:  J Neurol Sci       Date:  1984-04       Impact factor: 3.181

8.  Fibrous Astrocytes in senile dementia of the Alzheimer type.

Authors:  R Schechter; S H Yen; R D Terry
Journal:  J Neuropathol Exp Neurol       Date:  1981-03       Impact factor: 3.685

9.  Fibrous astrocytes in Alzheimer's disease and senile dementia of Alzheimer's type.

Authors:  G L Mancardi; B H Liwnicz; T I Mandybur
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

10.  Neuronal RNA in relation to neuronal loss and neurofibrillary pathology in the hippocampus in Alzheimer's disease.

Authors:  J A Doebler; W R Markesbery; A Anthony; R E Rhoads
Journal:  J Neuropathol Exp Neurol       Date:  1987-01       Impact factor: 3.685

View more
  2 in total

1.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 2.  The molecular mechanisms of scrapie encephalopathy and relevance to human neurodegenerative disease.

Authors:  W J Lukiw; H J Cho; J C Kaufmann; D R Crapper McLachlan
Journal:  Can J Vet Res       Date:  1990-01       Impact factor: 1.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.